• AFURESERTIB CHEMBL2219422 Antineoplastic

    Alternate Names:

    GSK2110183
    GSK2110183C
    Afuresertib
    N-[(2S)-1-AMINO-3-(3,4-DIFLUOROPHENYL)PROPAN-2-YL]-5-CHLORO-4-(4-CHLORO-2-METHYLPYRAZOL-3-YL)THIOPHENE-2-CARBOXAMIDE
    KB-334362
    HY-15966
    BC600705
    SCHEMBL1529680
    GTPL7890
    1047634-63-8
    GSK-2110183
    57826797
    GSK 2110183
    CS-3326
    75218467
    N-{(1S)-2-AMINO-1-[(3-FLUOROPHENYL)METHYL]ETHYL}-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-2-THIOPHENECARBOXAMIDE
    N-((1S)-1-(AMINOMETHYL)-2-(3-FLUOROPHENYL)ETHYL)-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)THIOPHENE-2-CARBOXAMIDE
    2-THIOPHENECARBOXAMIDE, N-((1S)-2-AMINO-1-((3-FLUOROPHENYL)METHYL)ETHYL)-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-
    1343402-83-4
    S7521,1047644-62-1
    D10381
    FT-0697009
    KB-137946
    HY-15727
    8739X25QI3
    ZINC43197674
    GSK 2110183C
    AOB87168
    AFJRDFWMXUECEW-LBPRGKRZSA-N
    AFURESRTIB (GSK2110183)
    SCHEMBL187686
    AFURESERTIB (GSK2110
    2-THIOPHENECARBOXAMIDE, N-[(1S)-2-AMINO-1-[(3-FLUOROPHENYL)METHYL]ETHYL]-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-, HYDROCHLORIDE (1:1)
    AFURESERTIB [USAN]
    AFURESERTIB (USAN)
    UNII-8739X25QI3
    1047644-62-1
    46843057
    249565581
    7890